The continuing unethical conduct of underpowered clinical trials.
about
Effect sizes for 2×2 contingency tablesTreatment of periodontal disease for glycaemic control in people with diabetesCurrent sample size conventions: flaws, harms, and alternativesWhat is a pilot or feasibility study? A review of current practice and editorial policyCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsSelf-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische KopfschmerzgesellschReporting of sample size calculation in randomised controlled trials: reviewProminent medical journals often provide insufficient information to assess the validity of studies with negative results.Dietary analysis and patterns of nutritional supplement use in normal and age-related macular disease affected subjects: a prospective cross-sectional studyEquipoise, design bias, and randomized controlled trials: the elusive ethics of new drug developmentPesticide testing on human subjects: weighing benefits and risks.Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: reviewRefinement of Experimental Design and Conduct in Laboratory Animal ResearchLinking vitamin d deficiency to inflammatory bowel diseaseRecruiting participants for randomized controlled trials of music therapy: a practical illustration.Delta inflation: a bias in the design of randomized controlled trials in critical care medicine.Extracting a maximum of useful information from statistical research data.Consent and confidentiality in the light of recent demands for data sharing.Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design.In the era of systematic reviews, does the size of an individual trial still matter.Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysisA tutorial on pilot studies: the what, why and how.An intervention to stop smoking among patients suspected of TB--evaluation of an integrated approach.Integrating statistical and clinical research elements in intervention-related grant applications: summary from an NIMH workshop.The cost of severe haemophilia in Europe: the CHESS study.No child left behind: Enrolling children and adults simultaneously in critical care randomized trialsMore ethical and more efficient clinical research: multiplex trial designAre surgical trials with negative results being interpreted correctly?Payment to healthcare professionals for patient recruitment to trials: a systematic review.Conducting a clinical study: A guide for good research practice.Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?Outcomes and statistical power in adult critical care randomized trialsQuestioning the methodologic superiority of 'placebo' over 'active' controlled trials.Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials.Ten categories of statistical errors: a guide for research in endocrinology and metabolism.Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial.Exploring patients' reasons for declining contact in a cognitive behavioural therapy randomised controlled trial in primary care.Single time point comparisons in longitudinal randomized controlled trials: power and bias in the presence of missing dataClinical trials in urology: how many patients are required to achieve statistically significant results?Interventions to increase enrollment in a large multicenter phase 3 trial of carotid stenting vs. endarterectomy
P2860
Q21133629-ED8A3A73-5380-450B-84DB-7DB481B3A2D4Q24235332-37873644-EC86-41AC-B505-83A9E87A65EAQ24288939-B2DDFB1F-F2A7-43A5-AF3C-8113BBAC0A15Q24288966-61DEEA7D-BFEA-4F2C-8708-1125307A38FFQ24614627-444C1419-7A21-4FDC-88F8-CEAD122F7246Q24619383-0FD58F0D-6BF2-4F4C-BED8-288F1350C674Q24645630-316DE0C7-E769-4F5A-A056-C8642E6D5F4EQ24793407-E165B61C-578A-45CF-BFE1-7727A54D10B6Q24800227-DBB14B6E-5751-4BC9-954A-B9E4F1B348A5Q24800828-B6020234-8B61-41D2-9A9F-3A58AB1FD8B6Q24813479-0C3A931C-DE19-44EB-9EDF-173624B945A9Q26827210-CCFB4F38-1060-4111-8442-3A1EA102BBB5Q26827610-FB6AFA8E-8B5A-45CA-8C87-69302F3CDF01Q27014858-CD9F1B61-44EC-4BFE-A58D-CEB145B9124BQ30369716-220C3201-6644-4768-9EBD-7B04FA757A65Q30435820-ABECB14F-A5BD-4371-B3C3-4F5603D48236Q30980965-F3389DBA-9D6F-4C24-876E-DA12BECEE042Q31042693-3A00E602-2A54-41BF-8627-CD3E798EC67EQ31106969-D839A5AA-79B6-4488-A927-B9932A31ECFCQ33313393-3A598971-9278-45B8-9F4C-B0AE5E8FDF8CQ33497692-16517C30-7406-4AB0-888A-EA818F0DEACEQ33522303-707C1A35-7499-416B-8FD7-A4E6290F0AA7Q33546154-46D0E94A-2B56-4151-BDFE-05FDB230C2D8Q33727260-203261D7-D18E-47F1-8553-823BA25FB5E8Q33750095-A8D5AC8A-41C1-4A82-B316-020E66C9BC66Q33992275-2BCCF9F5-053E-48B8-8B08-314A97F0705BQ34076637-5CDB54A4-75C5-4EE5-95A0-AFED2BD41C8AQ34193301-3692C23C-E0FA-42A5-94FA-B768797BBCD0Q34203860-916BA5D0-983F-4CD3-B306-9475F038CEF6Q34312556-145955F9-E8F4-4B9B-A51C-7F9851E5AAD5Q34466166-9FAD6E04-BADE-4BE3-AAB8-9D434046AACBQ34480195-CE18FF73-A391-43AC-9F2E-DC61B79123E0Q35016839-C6593E66-B3B1-4131-8ADC-0E317460CA1EQ35491460-1424D58A-6264-41FB-A61D-70C26F62EA32Q35686402-116A2CB7-5419-4ACD-9C0E-478BBB62B52CQ35690966-6237D639-D324-4B3C-B0B6-99CA75590620Q35916816-A9C7E76E-F0C1-4685-A53F-BB17C35BE1D3Q35986652-ED6B9EF6-85C4-4066-9617-69C88D602EC5Q36077345-5B8BEDFC-F313-4F17-9845-A96C49052AEBQ36103614-F39ADB24-230E-46FC-97B9-6CAC021BB19C
P2860
The continuing unethical conduct of underpowered clinical trials.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
The continuing unethical conduct of underpowered clinical trials.
@en
The continuing unethical conduct of underpowered clinical trials.
@nl
type
label
The continuing unethical conduct of underpowered clinical trials.
@en
The continuing unethical conduct of underpowered clinical trials.
@nl
prefLabel
The continuing unethical conduct of underpowered clinical trials.
@en
The continuing unethical conduct of underpowered clinical trials.
@nl
P2093
P356
P1476
The continuing unethical conduct of underpowered clinical trials.
@en
P2093
Jason H T Karlawish
Jesse A Berlin
Scott D Halpern
P304
P356
10.1001/JAMA.288.3.358
P407
P577
2002-07-01T00:00:00Z